Vildagliptin improves glucose sensitivity of cells in patients with type 2 diabetes: glucagon response to hypoglycemia

被引：0
|
作者：
Gautier, J. F.
Dejager, S. [1 ]
Foley, J. [2 ]
Halimi, S. [3 ]
Ahren, B. [4 ]
机构：
[1] Lab Novartis Pharma Sas, Rueil Malmaison, France
[2] Novartis, Clin Res, E Hanover, NJ USA
[3] CHU Grenoble, Serv Endocrinol Diabet Nutr, F-38043 Grenoble, France
[4] Lund Univ, Lund, Sweden
来源：
DIABETES & METABOLISM | 2009年 / 35卷
关键词：
D O I：
10.1016/S1262-3636(09)71722-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A8 / A8
页数：1
相关论文
共 50 条
  • [41] Efficacy of vildagliptin combined with pioglitazone in patients with type 2 diabetes
    Baron, M. A.
    Rosenstock, J.
    Bassiri, B.
    Rochette, E.
    Cressier, F.
    Amiour, Y.
    Hsu, C.
    Camisasca, R. -P.
    Dejager, S.
    LeBeaut, A.
    DIABETOLOGIA, 2006, 49 : 485 - 486
  • [42] Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT
    He, Yan-Ling
    Wang, Yibin
    Bullock, Julie M.
    Deacon, Carolyn F.
    Holst, Jens Juul
    Dunning, Beth E.
    Ligueros-Saylan, Monica
    Foley, James E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (05): : 633 - 641
  • [43] The rate of intraduodenal glucose delivery affects the lowering of blood glucose by vildagliptin in type 2 diabetes
    Wu, T.
    Zhang, X.
    Little, T. L.
    Bound, M. J.
    Standfield, S.
    Deacon, C. F.
    Horowitz, M.
    Jones, K. L.
    Rayner, C. K.
    DIABETOLOGIA, 2016, 59 : S377 - S377
  • [44] Vildagliptin in patients with type 2 diabetes mellitus and renal impairment
    Groop, Per-Henrik
    Dongre, Neelesh
    Kothny, Wolfgang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (02) : E12 - E13
  • [45] Glucagon Receptor Antagonism Lowers Fasting Glucose but Not Postprandial Glucose Excursions in Patients with Type 2 Diabetes
    Haedersdal, Sofie
    Lund, Asger
    Maagensen, Henrik
    Nielsen-Hannerup, Elisabeth
    Holst, Jens Juul
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES, 2017, 66 : A532 - A532
  • [46] Pharmacokinetics and Pharmacodynamics of Vildagliptin in Patients with Type 2 Diabetes Mellitus
    Yan-Ling He
    Denise Serra
    Yibin Wang
    Joelle Campestrini
    Gilles-Jacques Riviere
    Carolyn F. Deacon
    Jens J. Holst
    Sherwyn Schwartz
    Jace C. Nielsen
    Monica Ligueros-Saylan
    Clinical Pharmacokinetics, 2007, 46 : 577 - 588
  • [47] Hypoglycemia in patients with type 2 diabetes mellitus
    Miller, CD
    Phillips, LS
    Ziemer, DC
    Gallina, DL
    Cook, CB
    El-Kebbi, IM
    ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) : 1653 - 1659
  • [48] Pharmacokinetics and pharmacodynamics of vildagliptin in Japanese patients with Type 2 diabetes
    He, Y. -L.
    Yamaguchi, M.
    Ito, H.
    Terao, S.
    Sekiguchi, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (09) : 582 - 595
  • [49] INSULIN AND GLUCAGON RESPONSE TO GLUCOSE AND ARGININE IN 2 PATIENTS WITH AUTOIMMUNE DIABETES-MELLITUS
    DELPRETE, GF
    TIENGO, A
    BERSANI, G
    NOSADINI, R
    GAROTTI, C
    TRISOTTO, A
    HORMONE AND METABOLIC RESEARCH, 1976, 8 (02) : 149 - 150
  • [50] Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes
    Ichikawa, Raishi
    Takano, Koji
    Fujimoto, Kazumi
    Motomiya, Tetsuya
    Kobayashi, Masaki
    Kitamura, Tadahiro
    Shichiri, Masayoshi
    ENDOCRINE JOURNAL, 2019, 66 (08) : 663 - 675
12345